bosentan anhydrous has been researched along with Cardiomyopathy, Restrictive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alfano, D; Argiento, P; CalabrĂ², R; Cotrufo, M; D'Alto, M; Galdieri, N; Maiello, C; Russo, MG; Santoro, G; Sarubbi, B | 1 |
1 other study(ies) available for bosentan anhydrous and Cardiomyopathy, Restrictive
Article | Year |
---|---|
Complex multidrug therapy in a patient with pulmonary hypertension before and after orthotopic heart transplantation. A case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Cardiomyopathy, Restrictive; Contraindications; Drug Therapy, Combination; Epoprostenol; Heart Failure; Heart Transplantation; Humans; Hypertension, Pulmonary; Male; Sulfonamides | 2007 |